27.92 USD
+1.43 (+5.4%)
At close: Feb 2, 2026
27.92 USD
0 (0%)
After Hours: 2/2/2026, 4:02:31 PM
AMPH gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 191 industry peers in the Pharmaceuticals industry. AMPH scores excellent on profitability, but there are some minor concerns on its financial health. AMPH is valued quite cheap, while showing a decent growth score. This is a good combination! With these ratings, AMPH could be worth investigating further for value investing!.
1. Profitability
1.1 Basic Checks
- AMPH had positive earnings in the past year.
- In the past year AMPH had a positive cash flow from operations.
- Each year in the past 5 years AMPH has been profitable.
- In the past 5 years AMPH always reported a positive cash flow from operatings.
1.2 Ratios
- AMPH has a Return On Assets of 6.70%. This is amongst the best in the industry. AMPH outperforms 87.96% of its industry peers.
- Looking at the Return On Equity, with a value of 14.37%, AMPH belongs to the top of the industry, outperforming 87.96% of the companies in the same industry.
- The Return On Invested Capital of AMPH (8.51%) is better than 86.91% of its industry peers.
- AMPH had an Average Return On Invested Capital over the past 3 years of 12.92%. This is in line with the industry average of 12.82%.
- The last Return On Invested Capital (8.51%) for AMPH is well below the 3 year average (12.92%), which needs to be investigated, but indicates that AMPH had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.7% | ||
| ROE | 14.37% | ||
| ROIC | 8.51% |
ROA(3y)10.51%
ROA(5y)8.2%
ROE(3y)20.19%
ROE(5y)14.97%
ROIC(3y)12.92%
ROIC(5y)10.14%
1.3 Margins
- AMPH's Profit Margin of 15.43% is amongst the best of the industry. AMPH outperforms 87.43% of its industry peers.
- In the last couple of years the Profit Margin of AMPH has grown nicely.
- AMPH has a Operating Margin of 20.73%. This is amongst the best in the industry. AMPH outperforms 88.48% of its industry peers.
- In the last couple of years the Operating Margin of AMPH has grown nicely.
- Looking at the Gross Margin, with a value of 49.36%, AMPH is in the better half of the industry, outperforming 64.40% of the companies in the same industry.
- AMPH's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.73% | ||
| PM (TTM) | 15.43% | ||
| GM | 49.36% |
OM growth 3Y20.68%
OM growth 5YN/A
PM growth 3Y15.39%
PM growth 5Y7.52%
GM growth 3Y3.84%
GM growth 5Y4.54%
2. Health
2.1 Basic Checks
- AMPH has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- The number of shares outstanding for AMPH has been reduced compared to 1 year ago.
- Compared to 5 years ago, AMPH has more shares outstanding
- AMPH has a better debt/assets ratio than last year.
2.2 Solvency
- AMPH has an Altman-Z score of 2.40. This is not the best score and indicates that AMPH is in the grey zone with still only limited risk for bankruptcy at the moment.
- AMPH has a Altman-Z score of 2.40. This is in the better half of the industry: AMPH outperforms 64.40% of its industry peers.
- The Debt to FCF ratio of AMPH is 5.49, which is a neutral value as it means it would take AMPH, 5.49 years of fcf income to pay off all of its debts.
- AMPH has a better Debt to FCF ratio (5.49) than 82.20% of its industry peers.
- AMPH has a Debt/Equity ratio of 0.78. This is a neutral value indicating AMPH is somewhat dependend on debt financing.
- AMPH has a Debt to Equity ratio of 0.78. This is in the lower half of the industry: AMPH underperforms 70.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.78 | ||
| Debt/FCF | 5.49 | ||
| Altman-Z | 2.4 |
ROIC/WACC0.94
WACC9.03%
2.3 Liquidity
- AMPH has a Current Ratio of 3.12. This indicates that AMPH is financially healthy and has no problem in meeting its short term obligations.
- AMPH has a Current ratio (3.12) which is comparable to the rest of the industry.
- AMPH has a Quick Ratio of 2.21. This indicates that AMPH is financially healthy and has no problem in meeting its short term obligations.
- AMPH has a Quick ratio (2.21) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.12 | ||
| Quick Ratio | 2.21 |
3. Growth
3.1 Past
- AMPH shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -9.95%.
- The Earnings Per Share has been growing by 61.62% on average over the past years. This is a very strong growth
- AMPH shows a decrease in Revenue. In the last year, the revenue decreased by -0.03%.
- Measured over the past years, AMPH shows a quite strong growth in Revenue. The Revenue has been growing by 17.82% on average per year.
EPS 1Y (TTM)-9.95%
EPS 3Y41.58%
EPS 5Y61.62%
EPS Q2Q%-3.12%
Revenue 1Y (TTM)-0.03%
Revenue growth 3Y18.69%
Revenue growth 5Y17.82%
Sales Q2Q%0.33%
3.2 Future
- The Earnings Per Share is expected to grow by 0.14% on average over the next years.
- Based on estimates for the next years, AMPH will show a small growth in Revenue. The Revenue will grow by 4.14% on average per year.
EPS Next Y-8.73%
EPS Next 2Y-1.9%
EPS Next 3Y0.87%
EPS Next 5Y0.14%
Revenue Next Year-0.8%
Revenue Next 2Y1.99%
Revenue Next 3Y2.7%
Revenue Next 5Y4.14%
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 8.12, the valuation of AMPH can be described as very reasonable.
- 93.19% of the companies in the same industry are more expensive than AMPH, based on the Price/Earnings ratio.
- When comparing the Price/Earnings ratio of AMPH to the average of the S&P500 Index (28.32), we can say AMPH is valued rather cheaply.
- With a Price/Forward Earnings ratio of 7.52, the valuation of AMPH can be described as very cheap.
- 92.67% of the companies in the same industry are more expensive than AMPH, based on the Price/Forward Earnings ratio.
- When comparing the Price/Forward Earnings ratio of AMPH to the average of the S&P500 Index (25.57), we can say AMPH is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.12 | ||
| Fwd PE | 7.52 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, AMPH is valued cheaper than 91.62% of the companies in the same industry.
- AMPH's Price/Free Cash Flow ratio is rather cheap when compared to the industry. AMPH is cheaper than 90.05% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.56 | ||
| EV/EBITDA | 7.35 |
4.3 Compensation for Growth
- The excellent profitability rating of AMPH may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.13
EPS Next 2Y-1.9%
EPS Next 3Y0.87%
5. Dividend
5.1 Amount
- No dividends for AMPH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
AMPHASTAR PHARMACEUTICALS IN / AMPH FAQ
What is the fundamental rating for AMPH stock?
ChartMill assigns a fundamental rating of 6 / 10 to AMPH.
What is the valuation status of AMPHASTAR PHARMACEUTICALS IN (AMPH) stock?
ChartMill assigns a valuation rating of 8 / 10 to AMPHASTAR PHARMACEUTICALS IN (AMPH). This can be considered as Undervalued.
Can you provide the profitability details for AMPHASTAR PHARMACEUTICALS IN?
AMPHASTAR PHARMACEUTICALS IN (AMPH) has a profitability rating of 9 / 10.
What is the valuation of AMPHASTAR PHARMACEUTICALS IN based on its PE and PB ratios?
The Price/Earnings (PE) ratio for AMPHASTAR PHARMACEUTICALS IN (AMPH) is 8.12 and the Price/Book (PB) ratio is 1.65.